These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 28270295)

  • 1. Expressions of Immune Negative Regulator FoxP3+Treg and PD-L1 Protein in the Immune Microenvironment of Cervical Lesion.
    Ma Q; Zhao M; Wei X; Zhao J; Yang T; Zhang Q; Wang K; Yang X
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2017 Feb; 39(1):128-132. PubMed ID: 28270295
    [TBL] [Abstract][Full Text] [Related]  

  • 2. PD-L1
    Zhou L; Wang J; Lyu SC; Pan LC; Shi XJ; Du GS; He Q
    Technol Cancer Res Treat; 2021; 20():15330338211045820. PubMed ID: 34605709
    [No Abstract]   [Full Text] [Related]  

  • 3. Immune-checkpoint status in penile squamous cell carcinoma: a North American cohort.
    Cocks M; Taheri D; Ball MW; Bezerra SM; Del Carmen Rodriguez M; Ricardo BFP; Bivalacqua TJ; Sharma RB; Meeker A; Chaux A; Burnett AL; Netto GJ
    Hum Pathol; 2017 Jan; 59():55-61. PubMed ID: 27663086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Aberrant Expressions of Immune Factors Facilitate the Disequilibrium of Immune Status in Cervical Cancer.
    Zhao MY; Zhao J; Yang T; Wang L; Pei ML; Tian SJ; Yu Y; Yang XF
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2016 Oct; 38(5):522-527. PubMed ID: 27825407
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of indoleamine 2, 3-dioxygenase and the recruitment of Foxp3-expressing regulatory T cells in the development and progression of uterine cervical cancer.
    Nakamura T; Shima T; Saeki A; Hidaka T; Nakashima A; Takikawa O; Saito S
    Cancer Sci; 2007 Jun; 98(6):874-81. PubMed ID: 17433037
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nodal metastasis in cervical cancer occurs in clearly delineated fields of immune suppression in the pelvic lymph catchment area.
    Heeren AM; de Boer E; Bleeker MC; Musters RJ; Buist MR; Kenter GG; de Gruijl TD; Jordanova ES
    Oncotarget; 2015 Oct; 6(32):32484-93. PubMed ID: 26431490
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PD-L1 Expression Level Displays a Positive Correlation with Immune Response in Pancreatic Cancer.
    Zhao L; Cao Y
    Dis Markers; 2020; 2020():8843146. PubMed ID: 33062072
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohistochemical Analysis of Foxp3
    Stasikowska-Kanicka O; Wągrowska-Danilewicz M; Danilewicz M
    Pathol Oncol Res; 2018 Jul; 24(3):497-505. PubMed ID: 28669079
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Programmed death 1/programmed cell death-ligand 1 pathway participates in gastric surgery-induced imbalance of T-helper 17/regulatory T cells in mice.
    Dong L; Zheng X; Wang K; Wang G; Zou H
    J Trauma Acute Care Surg; 2018 Sep; 85(3):549-559. PubMed ID: 29554041
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tumour immune microenvironment in primary and metastatic papillary renal cell carcinoma.
    Eich ML; Chaux A; Mendoza Rodriguez MA; Guner G; Taheri D; Rodriguez Pena MDC; Sharma R; Allaf ME; Netto GJ
    Histopathology; 2020 Feb; 76(3):423-432. PubMed ID: 31494951
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of EBI3 on radiation-induced immunosuppression of cervical cancer HeLa cells by regulating Treg cells through PD-1/PD-L1 pathway.
    Zhang SA; Niyazi HE; Hong W; Tuluwengjiang GL; Zhang L; Zhang Y; Su WP; Bao YX
    Tumour Biol; 2017 Mar; 39(3):1010428317692237. PubMed ID: 28351328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3.
    Miller TJ; McCoy MJ; Hemmings C; Bulsara MK; Iacopetta B; Platell CF
    Pathology; 2017 Dec; 49(7):721-730. PubMed ID: 29102042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of the combination of sintilimab and chemotherapy on the tumor and paratumor PD-L1, IDO, TIM-3, FOXP3+ and CD8 expressions in patients with advanced esophageal squamous cell carcinoma.
    Zhang S; Cai H; Huang J; Wang G
    Thorac Cancer; 2022 Dec; 13(23):3284-3294. PubMed ID: 36288460
    [TBL] [Abstract][Full Text] [Related]  

  • 14. In-vitro effect of pembrolizumab on different T regulatory cell subsets.
    Toor SM; Syed Khaja AS; Alkurd I; Elkord E
    Clin Exp Immunol; 2018 Feb; 191(2):189-197. PubMed ID: 28963773
    [TBL] [Abstract][Full Text] [Related]  

  • 15. anlotinib alters tumor immune microenvironment by downregulating PD-L1 expression on vascular endothelial cells.
    Liu S; Qin T; Liu Z; Wang J; Jia Y; Feng Y; Gao Y; Li K
    Cell Death Dis; 2020 May; 11(5):309. PubMed ID: 32366856
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High and interrelated rates of PD-L1+CD14+ antigen-presenting cells and regulatory T cells mark the microenvironment of metastatic lymph nodes from patients with cervical cancer.
    Heeren AM; Koster BD; Samuels S; Ferns DM; Chondronasiou D; Kenter GG; Jordanova ES; de Gruijl TD
    Cancer Immunol Res; 2015 Jan; 3(1):48-58. PubMed ID: 25361854
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different pattern of PD-L1, IDO, and FOXP3 Tregs expression with survival in thymoma and thymic carcinoma.
    Wei YF; Chu CY; Chang CC; Lin SH; Su WC; Tseng YL; Lin CC; Yen YT
    Lung Cancer; 2018 Nov; 125():35-42. PubMed ID: 30429036
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in PD-L1-Expressing Macrophages and Immune Microenvironment in Testicular Germ Cell Tumors.
    Sadigh S; Farahani SJ; Shah A; Vaughn D; Lal P
    Am J Clin Pathol; 2020 Feb; 153(3):387-395. PubMed ID: 31802108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PD-L1 signal on liver dendritic cells is critical for Foxp3(+)CD4(+)CD25(+) Treg and liver tolerance induction in mice.
    Liu H; Bakthavatsalam R; Meng Z; Li Z; Li W; Perkins JD; Reyes J
    Transplant Proc; 2013 Jun; 45(5):1853-5. PubMed ID: 23769057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of PD-1/PD-L1 on immune microenvironment in oral leukoplakia and oral squamous cell carcinoma.
    Xu SB; Wang MY; Shi XZ; Wang Q; Yu M; Zhang W; Xu XH; Liu LK
    Oral Dis; 2023 Nov; 29(8):3268-3277. PubMed ID: 35921211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.